Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
Here are four takeaways:
1. Oregon Health & Science University in Portland enrolled the patient.
2. Ahmed M. Raslan, MD, and Jason J Chang, MD, both assistant professors of neurological surgery and study investigators, implanted the Neuro-Spinal Scaffold in the patient about 36 hours post-injury.
3. The INSPIRE study now has nine enrolled patients.
4. The study involves 25 clinical sites across the country.